All CARB-X articles
-
NewsRapid test for UTI wins $10m Longitude Prize on AMR to transform fight against superbugs
Sysmex Astrego’s PA-100 AST System has won the $10m (£8m) Longitude Prize on AMR. The winning test provides accurate antibiotic susceptibility results in 45 minutes – compared to the 2-3 day wait patients currently face.
-
NewsCARB-X funds Visby Medical to develop a portable rapid diagnostic for gonorrhea
Visby Medical aims to improve patients’ health outcomes and increase the lifespan of the last remaining antibiotic for resistant gonorrhea.
-
NewsNovo Nordisk Foundation partners with CARB-X to fight drug-resistant infections
The Novo Nordisk Foundation is committing up to $25 million to support the early-stage development of innovative tools to prevent, diagnose and treat the most dangerous drug-resistant bacterial infections. The three-year grant will go to the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), the leading global non-profit public-private partnership in this ...
-
NewsResearchers developing an oral therapeutic to treat drug-resistant bacterial pneumonia
Australian researchers aim to rescue common antibiotics with a new therapeutic approach, using a drug originally developed to treat neurodegenerative disorders.
